Impact of EXO1 (K589E) Genetic Variant on Breast Cancer Risk: Evidence From Bangladesh
Abstract
Exonuclease 1 ( EXO1 ) is a key nuclease in the DNA mismatch repair (MMR) pathway and is involved in correcting replication errors while maintaining genomic stability. The K589E (rs1047840) single nucleotide polymorphism (SNP) of EXO1 has been associated with cancer susceptibility in different populations. This study aimed to investigate the association between the EXO1 K589E polymorphism and breast cancer risk, as well as its relationship with selected clinicopathological characteristics in Bangladeshi women. Hospital-based case-control study. The present case–control study included 184 patients with histologically confirmed breast cancer and 200 age-matched cancer-free controls. Genotyping of the EXO1 K589E variant was carried out using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis and subsequently confirmed by direct sequencing. The associations between the polymorphism and breast cancer risk were assessed using logistic regression, with odds ratios (ORs) and corresponding 95% confidence intervals (CIs) calculated. The frequencies of G/G, G/A, and A/A genotypes were 49.5, 41.8, and 8.7% among cases, compared with 69, 27.5, and 3.5% among controls, respectively. Both the heterozygous (G/A) and homozygous variant (A/A) genotypes were significantly associated with elevated breast cancer risk (OR= 2.12, 95% CI= 1.37-3.28, p = 0.0007; OR= 3.46, 95 % CI= 1.37-8.76, p = 0.0086, respectively). The combined variant genotypes (G/A + A/A) conferred a 2.27-fold higher risk ( p = 0.0001), and the A allele was also strongly associated with breast cancer predisposition (OR= 2.01, 95% CI= 1.43-2.84, p = 0.0001). The association remained significant under codominant, dominant, recessive, overdominant, and log-additive genetic models. Significant correlations were observed between the variant genotype and menopausal status, body mass index (BMI), and tumor stage. The results indicate that the EXO1 K589E polymorphism is significantly associated with an increased risk of breast cancer in Bangladeshi women and may also be related to key clinicopathological features of the disease.